We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Low-Cost Transcriptional Diagnostic Accurately Categorizes Lymphomas

By LabMedica International staff writers
Posted on 14 Jun 2021
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. More...
The lymphatic system includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect all those areas as well as other organs throughout the body.

Many subtypes of lymphoma can be effectively treated with available therapies, including chemotherapies, monoclonal antibodies, or small molecule–targeted agents. As a result, there is a pressing need for inexpensive, accurate, and operator-independent diagnostics to guide therapeutic selection for patients with lymphoma.

An international team of medical scientists led by the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) collected Formalin-fixed Paraffin-embedded (FFPE) biopsy specimens obtained at Instituto de Cancerología y Hospital Dr. Bernardo Del Valle (INCAN, Guatemala City, Guatemala), that were performed because of clinical suspicion of lymphoma over a 13-year period. This included 3,015 tissue blocks from 1,836 individual patients. Most biopsy specimens were from lymph nodes or secondary lymphoid tissue, but additional extranodal sites (e.g., palate, testicle, eyelid, femur, thyroid, skin, mesentery, tongue, breast, and lung) were included.

One-half of each FFPE block and H&E slides were generated from whole sections and reviewed by two expert hematopathologists. Representative areas were selected, and two cores from each sample were included for tissue microarray (TMA) construction. TMAs were sectioned at 4-μm thickness and subjected to immunohistochemistry (IHC) per routine protocol on automated Leica BOND-III immunostainers (Leica Biosystems, Buffalo Grove, IL, USA) or BenchMark ULTRA, Roche/Ventana Medical Systems, Tucson, AZ, USA). Capillary electrophoresis was run on an Applied Biosystems 3500 or SeqStudio Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA).

The team established a chemical ligation probe-based assay (CLPA) that quantifies expression of 37 genes by capillary electrophoresis with reagent/consumable cost of approximately USD 10/sample. To assign bins based on gene expression, 13 models were evaluated as candidate base learners, and class probabilities from each model were then used as predictors in an extreme gradient boosting super learner. Cases with call probabilities < 60% were classified as indeterminate. Four (2%) of 194 biopsy specimens in storage <3 years experienced assay failure. Diagnostic samples were divided into 397 (70%) training and 163 (30%) validation cohorts. Overall accuracy for the validation cohort was 86%.

After excluding 28 (17%) indeterminate calls, accuracy increased to 94%. Concordance was 97% for a set of 37 high-probability calls assayed by CLPA in both the USA and Guatemala. Accuracy for a cohort of 39 relapsed/refractory biopsy specimens was 79% and 88%, respectively, after excluding indeterminate cases. Machine-learning analysis of gene expression accurately classifies paraffin-embedded lymphoma biopsy specimens and could transform diagnosis in lower- and middle-income countries. The study was published on May 14, 2021 in the journal Blood Advances.

Related Links:
Fred Hutchinson Cancer Research Center
Instituto de Cancerología y Hospital Dr. Bernardo Del Valle
Leica Biosystems
Roche/Ventana Medical Systems
Thermo Fisher Scientific



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.